Jefferies Financial Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-129,400
Closed -$15M 2102
2023
Q3
$15M Buy
+129,400
New +$13.9M 0.13% 112

Other funds holding HZNP

Jefferies Financial Group's HZNP Position: Q4 2023 in Review

Jefferies Financial Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 47,700 shares — an estimated $5.52M sold.

Jefferies Financial Group first reported a position in HZNP in Q4 2022 and held it in 3 quarters. The position peaked at $5.52M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Jefferies Financial Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 47,700 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $5.52M.
  • Jefferies Financial Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and held it in 3 quarters.
  • Jefferies Financial Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.52M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Jefferies Financial Group's 13F filing for Q4 2023, filed 14 Feb 2024.